Clinical Trial

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

Recruiting
View on ClinicalTrials.gov →
Summary
The study is a prospective, longitudinal, non-interventional, multicenter study of participants with HNSCC who will have tissue and blood based molecular biomarker profiling during their standard of care treatment.
Protocol Amendment History 25 amendments
This ClinicalTrials.gov record has been amended 25 times since 2023-11-30; most recent amendment 2026-06-10.
Status change: Not Yet Recruiting → Recruiting 2024-04-02
Trial Details
NCT Number NCT06163534
Lead Sponsor Tempus AI
Collaborators: AstraZeneca
Conditions Head and Neck Squamous Cell Carcinoma
Enrollment 500 participants
Start Date 2024-08-01
Primary Completion 2028-03-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-12